NO146538C - Analogifremgangsmaate for fremstilling av fysiologisk aktive n-substituerte prostaglandinkarboksamider - Google Patents
Analogifremgangsmaate for fremstilling av fysiologisk aktive n-substituerte prostaglandinkarboksamiderInfo
- Publication number
- NO146538C NO146538C NO2379/73A NO237973A NO146538C NO 146538 C NO146538 C NO 146538C NO 2379/73 A NO2379/73 A NO 2379/73A NO 237973 A NO237973 A NO 237973A NO 146538 C NO146538 C NO 146538C
- Authority
- NO
- Norway
- Prior art keywords
- carboxamids
- prostaglandine
- substituted
- preparation
- physiologically active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5407—Acyclic saturated phosphonium compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO752272A NO146773C (no) | 1972-06-07 | 1975-06-25 | Utgangsforbindelse for fremstilling av n-substituerte prostaglandin-karboksamider |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26051872A | 1972-06-07 | 1972-06-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO146538B NO146538B (no) | 1982-07-12 |
NO146538C true NO146538C (no) | 1982-10-20 |
Family
ID=22989486
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO2379/73A NO146538C (no) | 1972-06-07 | 1973-06-06 | Analogifremgangsmaate for fremstilling av fysiologisk aktive n-substituerte prostaglandinkarboksamider |
NO740850A NO142784C (no) | 1972-06-07 | 1974-03-11 | Forbindelse for fremstilling av n-substituerte prostaglandin-karboksamider |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO740850A NO142784C (no) | 1972-06-07 | 1974-03-11 | Forbindelse for fremstilling av n-substituerte prostaglandin-karboksamider |
Country Status (24)
Country | Link |
---|---|
JP (2) | JPS5715591B2 (no) |
AR (1) | AR207434A1 (no) |
AT (1) | AT340069B (no) |
BE (1) | BE800580A (no) |
CA (1) | CA985280A (no) |
CH (3) | CH591511A5 (no) |
CS (1) | CS200166B2 (no) |
DD (2) | DD115687A5 (no) |
DE (1) | DE2329092A1 (no) |
ES (3) | ES415611A1 (no) |
FI (1) | FI58327C (no) |
FR (2) | FR2187344B1 (no) |
GB (2) | GB1439512A (no) |
HU (3) | HU170200B (no) |
IE (1) | IE38058B1 (no) |
IL (2) | IL42385A (no) |
IN (1) | IN138966B (no) |
LU (1) | LU67754A1 (no) |
NL (2) | NL160814C (no) |
NO (2) | NO146538C (no) |
PH (2) | PH14204A (no) |
SE (3) | SE415883B (no) |
YU (1) | YU36498B (no) |
ZA (1) | ZA733763B (no) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX3291E (es) * | 1975-04-23 | 1980-08-22 | Upjohn Co | Procedimiento para preparar analogos de prostaglandinas |
US6395787B1 (en) | 2000-02-08 | 2002-05-28 | Allergan Sales, Inc. | Ocular hypotensive lipids |
US6476064B1 (en) * | 2001-06-13 | 2002-11-05 | Allergan, Inc. | Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3187043A (en) * | 1962-05-18 | 1965-06-01 | Monsanto Co | Monohalophosphonium halides |
-
1973
- 1973-01-01 AR AR248467A patent/AR207434A1/es active
- 1973-05-28 SE SE7307522A patent/SE415883B/xx unknown
- 1973-05-29 GB GB4209675A patent/GB1439512A/en not_active Expired
- 1973-05-29 IL IL42385A patent/IL42385A/xx unknown
- 1973-05-29 GB GB2561373A patent/GB1439511A/en not_active Expired
- 1973-05-29 CA CA172,672A patent/CA985280A/en not_active Expired
- 1973-05-30 FI FI1762/73A patent/FI58327C/fi active
- 1973-05-31 IN IN1278/CAL/73A patent/IN138966B/en unknown
- 1973-06-04 PH PH14689A patent/PH14204A/en unknown
- 1973-06-04 ZA ZA733763A patent/ZA733763B/xx unknown
- 1973-06-05 IE IE896/73A patent/IE38058B1/xx unknown
- 1973-06-06 NO NO2379/73A patent/NO146538C/no unknown
- 1973-06-06 HU HUPI477A patent/HU170200B/hu unknown
- 1973-06-06 HU HUPI384A patent/HU170487B/hu unknown
- 1973-06-06 ES ES415611A patent/ES415611A1/es not_active Expired
- 1973-06-06 HU HUPI476A patent/HU170491B/hu unknown
- 1973-06-06 NL NL7307867.A patent/NL160814C/xx not_active IP Right Cessation
- 1973-06-07 DD DD180810*A patent/DD115687A5/xx unknown
- 1973-06-07 AT AT504873A patent/AT340069B/de not_active IP Right Cessation
- 1973-06-07 DD DD171393A patent/DD109211A5/xx unknown
- 1973-06-07 BE BE1005125A patent/BE800580A/xx not_active IP Right Cessation
- 1973-06-07 CH CH1535876A patent/CH591511A5/xx not_active IP Right Cessation
- 1973-06-07 FR FR7320753A patent/FR2187344B1/fr not_active Expired
- 1973-06-07 CS CS734136A patent/CS200166B2/cs unknown
- 1973-06-07 DE DE2329092A patent/DE2329092A1/de not_active Ceased
- 1973-06-07 CH CH1535976A patent/CH605887A5/xx not_active IP Right Cessation
- 1973-06-07 YU YU01526/73A patent/YU36498B/xx unknown
- 1973-06-07 LU LU67754A patent/LU67754A1/xx unknown
- 1973-06-07 CH CH831273A patent/CH593929A5/xx not_active IP Right Cessation
- 1973-06-07 JP JP6435173A patent/JPS5715591B2/ja not_active Expired
-
1974
- 1974-03-11 NO NO740850A patent/NO142784C/no unknown
- 1974-09-26 ES ES430417A patent/ES430417A1/es not_active Expired
- 1974-09-26 ES ES430416A patent/ES430416A1/es not_active Expired
-
1975
- 1975-06-06 FR FR7517790A patent/FR2273814A1/fr active Granted
- 1975-06-25 PH PH17314A patent/PH13092A/en unknown
-
1976
- 1976-07-19 SE SE7608225A patent/SE7608225L/xx not_active Application Discontinuation
- 1976-07-19 SE SE7608224A patent/SE418744B/xx unknown
-
1977
- 1977-02-23 IL IL51525A patent/IL51525A0/xx unknown
-
1978
- 1978-12-14 NL NL7812163A patent/NL7812163A/xx not_active Application Discontinuation
-
1981
- 1981-06-10 JP JP8940881A patent/JPS5731692A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO138335C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive alkanolaminer | |
NO140381C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner | |
NO141800C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner. | |
NO143460C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner. | |
NO143575C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive prostansyre-derivater | |
NO138566C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater | |
NO149281C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater | |
NO145056C (no) | (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater | |
SE395149B (sv) | Forfarande for framstellning av dibenso-tiepinylpiperazinderivat | |
SE401676B (sv) | Forfarande for framstellning av dibensofuranderivat | |
NO140977C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-amino-1,4-dihydropyridiner | |
NO138999C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner | |
NO137899C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n (1h-tetrazol-5-yl)-kinaldamider | |
NO142838C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater | |
NO141850C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater. | |
NO143064C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner | |
NO143741C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive prostaglandinforbindelser av e- og f-serien | |
SE400551B (sv) | Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat | |
NO137858C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner | |
NO139088C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2beta,16beta-diamino-5alfa-androstaner | |
NO142077C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-cyclohexyl-3-pyrrolidinyl)-benzamider | |
NO137728C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater | |
NO138026C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive n-benzhydryl-n`-p-hydroksybenzylpiperaziner | |
NO145238C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater | |
NO144344C (no) | Fremgangsmaate for fremstilling av terapeutisk aktive n-arylsulfonyl n`-(3-azabicykloalkyl)urinstoffer |